Prevention and Treatment for Covid-19 Assoiated Severe Pnuemonia in The Gambia: A randomized clinical Trial - Funded by UKRI
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-112
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
UK Research and Innovation (UKRI)Principal Investigator
Professor Anna RocaResearch Location
GambiaLead Research Institution
MRC Unit The Gambia at the London School of Hygiene & Tropical MedicineResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
The study intends to evaluate the efficacy of a chosen drug in preventing progression to severe pneumonia, and to evaluate the efficacy of prophylactic chosen drug in preventing COVID19 infection among house hold contacts (both symptomatic and asymptomatic).